Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation

Kei Takeshita, Yukio Suzuki, Kazumi Nishio, Osamu Takeuchi, Kyoko Toda, Hiroyasu Kudo, Naoki Miyao, Makoto Ishii, Nagato Sato, Katsuhiko Naoki, Takuya Aoki, Koichi Suzuki, Rika Hiraoka, Kazuhiro Yamaguchi

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Although permissive hypercapnia improves the prognosis of patients with acute respiratory distress syndrome, it has not been conclusively determined whether hypercapnic acidosis (HA) is harmful or beneficial to sustained inflammation of the lung. The present study was designed to explore the molecular mechanism of HA in modifying lipopolysaccharide (LPS)-associated signals in pulmonary endothelial cells. LPS elicited degradation of inhibitory protein κB (IκB)-α, but not IκB-β, resulting in activation of nuclear factor (NF)-κB in human pulmonary artery endothelial cells. Exposure to HA significantly attenuated LPS-induced NF-κB activation through suppressing IκB-α degradation. Isocapnic acidosis and buffered hypercapnia showed qualitatively similar but quantitatively smaller effects. HA did not attenuate the LPS-enhanced activation of activator protein-1. Following the reduced NF-κB activation, HA suppressed the mRNA and protein levels of intercellular adhesion molecule-1 and interleukin-8, resulting in a decrease in both lactate dehydrogenase release into the medium and neutrophil adherence to LPS-activated human pulmonary artery endothelial cells. In contrast, HA did not inhibit LPS-enhanced neutrophil expression of integrin, Mac-1. Based on these findings, we concluded that hypercapnic acidosis would have anti-inflammatory effects essentially through a mechanism inhibiting NF-κB activation, leading to downregulation of intercellular adhesion molecule-1 and interleukin-8, which in turn inhibits neutrophil adherence to pulmonary endothelial cells.

Original languageEnglish
Pages (from-to)124-132
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume29
Issue number1
DOIs
Publication statusPublished - 2003 Jul 1
Externally publishedYes

Fingerprint

Acidosis
Endotoxins
Lipopolysaccharides
Chemical activation
Endothelial cells
Endothelial Cells
Intercellular Adhesion Molecule-1
Interleukin-8
Neutrophils
Hypercapnia
Pulmonary Artery
Degradation
Transcription Factor AP-1
L-Lactate Dehydrogenase
Integrins
Lung
Adult Respiratory Distress Syndrome
Anti-Inflammatory Agents
Proteolysis
Pneumonia

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Cite this

Takeshita, K., Suzuki, Y., Nishio, K., Takeuchi, O., Toda, K., Kudo, H., ... Yamaguchi, K. (2003). Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation. American Journal of Respiratory Cell and Molecular Biology, 29(1), 124-132. https://doi.org/10.1165/rcmb.2002-0126OC

Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation. / Takeshita, Kei; Suzuki, Yukio; Nishio, Kazumi; Takeuchi, Osamu; Toda, Kyoko; Kudo, Hiroyasu; Miyao, Naoki; Ishii, Makoto; Sato, Nagato; Naoki, Katsuhiko; Aoki, Takuya; Suzuki, Koichi; Hiraoka, Rika; Yamaguchi, Kazuhiro.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 29, No. 1, 01.07.2003, p. 124-132.

Research output: Contribution to journalArticle

Takeshita, K, Suzuki, Y, Nishio, K, Takeuchi, O, Toda, K, Kudo, H, Miyao, N, Ishii, M, Sato, N, Naoki, K, Aoki, T, Suzuki, K, Hiraoka, R & Yamaguchi, K 2003, 'Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation', American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 1, pp. 124-132. https://doi.org/10.1165/rcmb.2002-0126OC
Takeshita, Kei ; Suzuki, Yukio ; Nishio, Kazumi ; Takeuchi, Osamu ; Toda, Kyoko ; Kudo, Hiroyasu ; Miyao, Naoki ; Ishii, Makoto ; Sato, Nagato ; Naoki, Katsuhiko ; Aoki, Takuya ; Suzuki, Koichi ; Hiraoka, Rika ; Yamaguchi, Kazuhiro. / Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation. In: American Journal of Respiratory Cell and Molecular Biology. 2003 ; Vol. 29, No. 1. pp. 124-132.
@article{d11b2496070342e2877b621325526da9,
title = "Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation",
abstract = "Although permissive hypercapnia improves the prognosis of patients with acute respiratory distress syndrome, it has not been conclusively determined whether hypercapnic acidosis (HA) is harmful or beneficial to sustained inflammation of the lung. The present study was designed to explore the molecular mechanism of HA in modifying lipopolysaccharide (LPS)-associated signals in pulmonary endothelial cells. LPS elicited degradation of inhibitory protein κB (IκB)-α, but not IκB-β, resulting in activation of nuclear factor (NF)-κB in human pulmonary artery endothelial cells. Exposure to HA significantly attenuated LPS-induced NF-κB activation through suppressing IκB-α degradation. Isocapnic acidosis and buffered hypercapnia showed qualitatively similar but quantitatively smaller effects. HA did not attenuate the LPS-enhanced activation of activator protein-1. Following the reduced NF-κB activation, HA suppressed the mRNA and protein levels of intercellular adhesion molecule-1 and interleukin-8, resulting in a decrease in both lactate dehydrogenase release into the medium and neutrophil adherence to LPS-activated human pulmonary artery endothelial cells. In contrast, HA did not inhibit LPS-enhanced neutrophil expression of integrin, Mac-1. Based on these findings, we concluded that hypercapnic acidosis would have anti-inflammatory effects essentially through a mechanism inhibiting NF-κB activation, leading to downregulation of intercellular adhesion molecule-1 and interleukin-8, which in turn inhibits neutrophil adherence to pulmonary endothelial cells.",
author = "Kei Takeshita and Yukio Suzuki and Kazumi Nishio and Osamu Takeuchi and Kyoko Toda and Hiroyasu Kudo and Naoki Miyao and Makoto Ishii and Nagato Sato and Katsuhiko Naoki and Takuya Aoki and Koichi Suzuki and Rika Hiraoka and Kazuhiro Yamaguchi",
year = "2003",
month = "7",
day = "1",
doi = "10.1165/rcmb.2002-0126OC",
language = "English",
volume = "29",
pages = "124--132",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation

AU - Takeshita, Kei

AU - Suzuki, Yukio

AU - Nishio, Kazumi

AU - Takeuchi, Osamu

AU - Toda, Kyoko

AU - Kudo, Hiroyasu

AU - Miyao, Naoki

AU - Ishii, Makoto

AU - Sato, Nagato

AU - Naoki, Katsuhiko

AU - Aoki, Takuya

AU - Suzuki, Koichi

AU - Hiraoka, Rika

AU - Yamaguchi, Kazuhiro

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Although permissive hypercapnia improves the prognosis of patients with acute respiratory distress syndrome, it has not been conclusively determined whether hypercapnic acidosis (HA) is harmful or beneficial to sustained inflammation of the lung. The present study was designed to explore the molecular mechanism of HA in modifying lipopolysaccharide (LPS)-associated signals in pulmonary endothelial cells. LPS elicited degradation of inhibitory protein κB (IκB)-α, but not IκB-β, resulting in activation of nuclear factor (NF)-κB in human pulmonary artery endothelial cells. Exposure to HA significantly attenuated LPS-induced NF-κB activation through suppressing IκB-α degradation. Isocapnic acidosis and buffered hypercapnia showed qualitatively similar but quantitatively smaller effects. HA did not attenuate the LPS-enhanced activation of activator protein-1. Following the reduced NF-κB activation, HA suppressed the mRNA and protein levels of intercellular adhesion molecule-1 and interleukin-8, resulting in a decrease in both lactate dehydrogenase release into the medium and neutrophil adherence to LPS-activated human pulmonary artery endothelial cells. In contrast, HA did not inhibit LPS-enhanced neutrophil expression of integrin, Mac-1. Based on these findings, we concluded that hypercapnic acidosis would have anti-inflammatory effects essentially through a mechanism inhibiting NF-κB activation, leading to downregulation of intercellular adhesion molecule-1 and interleukin-8, which in turn inhibits neutrophil adherence to pulmonary endothelial cells.

AB - Although permissive hypercapnia improves the prognosis of patients with acute respiratory distress syndrome, it has not been conclusively determined whether hypercapnic acidosis (HA) is harmful or beneficial to sustained inflammation of the lung. The present study was designed to explore the molecular mechanism of HA in modifying lipopolysaccharide (LPS)-associated signals in pulmonary endothelial cells. LPS elicited degradation of inhibitory protein κB (IκB)-α, but not IκB-β, resulting in activation of nuclear factor (NF)-κB in human pulmonary artery endothelial cells. Exposure to HA significantly attenuated LPS-induced NF-κB activation through suppressing IκB-α degradation. Isocapnic acidosis and buffered hypercapnia showed qualitatively similar but quantitatively smaller effects. HA did not attenuate the LPS-enhanced activation of activator protein-1. Following the reduced NF-κB activation, HA suppressed the mRNA and protein levels of intercellular adhesion molecule-1 and interleukin-8, resulting in a decrease in both lactate dehydrogenase release into the medium and neutrophil adherence to LPS-activated human pulmonary artery endothelial cells. In contrast, HA did not inhibit LPS-enhanced neutrophil expression of integrin, Mac-1. Based on these findings, we concluded that hypercapnic acidosis would have anti-inflammatory effects essentially through a mechanism inhibiting NF-κB activation, leading to downregulation of intercellular adhesion molecule-1 and interleukin-8, which in turn inhibits neutrophil adherence to pulmonary endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=0038125959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038125959&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2002-0126OC

DO - 10.1165/rcmb.2002-0126OC

M3 - Article

C2 - 12600832

AN - SCOPUS:0038125959

VL - 29

SP - 124

EP - 132

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 1

ER -